Investing.com - UBS has lowered its price target on Neurocrine Biosciences (NASDAQ:NBIX) to $188.00 from $195.00 while maintaining a Buy rating on the stock. Currently trading at $137.42, Neurocrine ...

Upslope Capital delivered a 14.8% net return in FY 2025, significantly outperforming the S&P Midcap 400 with reduced ...

The first part of Ottawa’s strategy to boost biofuels and shore up domestic demand for canola came into force on Jan 1. The $370-million Biofuel Production Incentive will be given to biofuel producers ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Lea Uradu, J.D., is a Maryland state registered tax preparer, state-certified notary public, ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Membership (fee-based) Forbes Technology Council is an invitation-only, fee-based ...

Betting sites not on BetStop provide more features and flexibility, along with an international flair so you can enjoy all the sports you love. From big bonuses to in-play betting and cryptocurrency ...

An office boy at Biograph learns how to operate a camera, and when he spies the boss kissing his secretary, he records their illicit act.